The global Cardiac monitoring market size was estimated at USD 28361 million in 2025 and is expected to reach USD 39115.64 million by 2032, growing at a CAGR of 4.7% from 2025 to 2032. The strongest growth driver is the expansion of ambulatory and remote-care pathways that require longer-duration rhythm capture beyond short in-facility exams, increasing utilization of monitoring across screening, diagnosis, post-discharge surveillance, and chronic disease follow-up. North America continues to anchor demand, supported by high adoption of connected monitoring workflows, with Europe and Asia Pacific contributing incremental expansion through broader access and modernization of cardiac care delivery.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2024
Base Year
2025
Forecast Period
2026-2032
Cardiac Monitoring Market Size 2025
USD 28361 million
Cardiac Monitoring Market, CAGR
4.7%
Cardiac Monitoring Market Size 2032
USD 39115.64 million
Key Market Trends & Insights
The Cardiac monitoring market is projected to expand from USD 28361 million in 2025 to USD 39115.64 million by 2032 at a CAGR of 4.7% during 2025–2032.
Resting ECG accounted for the largest share of 33.4% in 2025, reflecting the foundational role of ECG in screening, triage, and longitudinal rhythm assessment.
Conventional (Wired) systems held 55.3% revenue share in 2025, indicating continued reliance on established in-hospital monitoring infrastructure.
Hospitals represented 48.1% share in 2025, supported by acute-care telemetry needs, specialist oversight, and higher patient throughput for cardiac evaluation.
North America held 42.8% share in 2025, indicating the largest regional revenue contribution within the Cardiac monitoring market.
Segment Analysis
Cardiac monitoring market demand is increasingly shaped by the need to capture intermittent and asymptomatic events over longer periods, which strengthens adoption of ambulatory and wearable modalities alongside established in-facility monitoring. Provider priorities are shifting toward workflow efficiency, signal quality, and actionable interpretation, which elevates the value of connectivity and analytics in daily operations. Care pathway redesign toward earlier detection and continuous follow-up expands monitoring volumes across screening programs, outpatient cardiology, and post-procedure surveillance. Purchasing decisions also reflect integration requirements across enterprise systems, clinical staffing constraints, and expectations for scalable remote monitoring.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Cardiac monitoring market product preference varies by clinical setting and diagnostic intent. Short-duration diagnostic use cases support routine ECG utilization, while suspected paroxysmal arrhythmias increase demand for longer monitoring windows through Holter, event monitoring, and telemetry-based solutions. Implantable monitoring supports prolonged surveillance in hard-to-capture cases, especially when symptom frequency is low and diagnostic yield is critical. Wearable patch monitors continue to gain attention in ambulatory pathways due to simplified patient adherence and operational efficiency for high-volume programs.
By Product Type Insights
Resting ECG accounted for the largest share of 33.4% in 2025. Resting ECG remains widely deployed because ECG-based diagnostics are embedded across primary care, emergency assessment, inpatient telemetry workflows, and routine cardiology follow-up. Broad availability, standardized interpretation protocols, and relatively low operational complexity sustain high procedure volumes across care settings. Demand also benefits from rising screening intensity and structured monitoring in chronic cardiovascular management programs.
By Technology Insights
Conventional (Wired) accounted for the largest share of 55.3% in 2025. Conventional infrastructure remains dominant due to long replacement cycles for hospital monitoring systems and established clinical workflows built around wired bedside and telemetry architectures. Standardized device management, clinical familiarity, and compatibility with existing hospital IT and monitoring stations help sustain utilization. Wireless and wearable growth continues, but conventional deployment retains the largest installed base in acute care.
By End User Insights
Hospitals accounted for the largest share of 48.1% in 2025. Hospitals lead demand because telemetry monitoring supports acute cardiac evaluation, peri-procedural surveillance, and escalation pathways for rhythm-related events. Centralized staffing and specialist availability enable continuous monitoring and rapid clinical response in higher-risk populations. Hospital procurement also tends to favor integrated monitoring ecosystems that support multi-parameter surveillance and broader enterprise workflows.
Cardiac Monitoring Market Drivers
Expanding Burden Of Cardiovascular Disease And Arrhythmia Detection Needs
Cardiac monitoring market growth is supported by a rising clinical need to detect arrhythmias earlier and monitor high-risk patients more consistently. Increasing prevalence of chronic cardiovascular conditions raises diagnostic volumes across outpatient and inpatient settings. Greater clinical emphasis on identifying intermittent rhythm abnormalities increases demand for longer monitoring windows compared with single-visit assessments. Health systems also prioritize continuity of care, which elevates monitoring frequency across follow-up and post-discharge pathways.
Shift Toward Ambulatory And Remote Monitoring Pathways
Cardiac monitoring market adoption increases as care delivery moves from inpatient environments to ambulatory settings and home-based follow-up. Remote monitoring programs reduce avoidable visits and enable earlier intervention when clinically significant rhythm events occur. Patient convenience and adherence considerations support broader use of wearable and patch-based solutions in long-duration surveillance. Payer and provider focus on efficient utilization further accelerates deployment of scalable monitoring services.
Technology Integration And Analytics-Driven Workflow Efficiency
Cardiac monitoring market differentiation increasingly depends on connectivity, analytics, and signal triage features that improve clinician efficiency. Integration with enterprise systems reduces fragmentation across ECG review, telemetry oversight, and remote monitoring coordination. Analytics-supported interpretation improves prioritization of actionable events and reduces operational strain from non-actionable alerts. Health systems increasingly value platforms that support standardized reporting and multi-site deployment across networks.
For instance, GE Healthcare’s MUSE cardiac information management system — used by 87% of top cardiac hospitals in the United States — connects directly with hospital electronic medical records to manage and streamline the flow of cardiac information and ECG data across care settings.
Growth In Procedure Volumes And Post-Acute Surveillance Programs
Cardiac monitoring market demand benefits from growing procedural volumes and a greater need for surveillance during recovery and long-term management. Post-procedure monitoring supports early detection of complications and strengthens clinical outcomes through timely escalation. Clinical pathways increasingly incorporate structured follow-up, which increases monitoring utilization in diagnostic centers and outpatient cardiology. Expansion of specialized cardiac services across emerging markets further supports incremental equipment and service adoption.
For instance, Medtronic’s Reveal LINQ insertable cardiac monitor demonstrated that cardiologists are 3.6 times more likely to reach a diagnosis for unexplained syncope using ICMs versus conventional monitoring strategies, and between 70% and 86% of patients ultimately diagnosed with an ICM would have remained undiagnosed under conventional monitoring approaches alone.
Cardiac Monitoring Market Challenges
Cardiac monitoring market execution faces operational challenges related to data volume, signal noise, and alert burden in high-throughput environments. Clinician time constraints and staffing shortages intensify the need for efficient triage and streamlined interpretation processes. Interoperability limitations across devices, software, and enterprise systems can slow deployment and reduce workflow benefits. Patient adherence challenges also affect longer-duration ambulatory monitoring, influencing diagnostic yield and program efficiency.
For instance, Philips reports that its Cardiologs AI platform was built on more than 200 million recordings, is used to help diagnose more than 2 million patients each year across 5 continents, reduces Holter analysis time by 42%, detects more than 20 event types, and lowered atrial fibrillation false positives from 17.2% to 1.5% in validation work, highlighting how vendors are using automation to reduce interpretation burden and noise-related workflow inefficiencies.
Cardiac monitoring market expansion is constrained by affordability and reimbursement variability across regions and care settings. Procurement decisions often require clear cost-benefit justification, especially for connected ecosystems and advanced analytics. Regulatory and compliance requirements for software-enabled monitoring can increase time-to-market and validation costs. Service scaling can also be limited by operational capacity for data review and clinical oversight.
Cardiac Monitoring Market Trends and Opportunities
Cardiac monitoring market opportunity is expanding through broader adoption of wireless and wearable monitoring aligned with outpatient growth. Care models increasingly prioritize continuous surveillance for targeted cohorts, supporting new deployment programs across provider networks. Integration of monitoring outputs into longitudinal patient records improves care coordination and strengthens clinical adoption. Demand for simplified patient experience creates openings for patch-based and streamlined multi-day monitoring workflows.
For instance, iRhythm’s Zio adhesive patch is indicated for up to 14 days of continuous monitoring; across 22 studies, the unweighted mean wear time was 10.4 days, and a comparative study found the device detected 57% more arrhythmia events than 24-hour Holter monitoring, while 81% of patients preferred Zio over Holter monitors.
Cardiac monitoring market evolution increasingly favors analytics-led differentiation and enterprise connectivity. AI-enabled interpretation and workflow automation can reduce review burden and support faster decision-making in resource-constrained environments. Monitoring vendors can expand value through integrated platforms that connect diagnostics, telemetry, and remote follow-up into unified workflows. Growth opportunities also emerge from partnerships that combine devices, services, and clinical programs for scalable monitoring adoption.
Regional Insights
North America
North America accounted for 42.8% share in 2025. Cardiac monitoring market demand in the region is anchored by advanced care infrastructure and strong uptake of connected monitoring workflows across hospital and ambulatory pathways. High screening intensity and structured follow-up programs increase utilization across diagnostic and chronic management settings. Enterprise integration expectations support replacement and upgrade cycles for monitoring ecosystems. Provider focus on remote pathways also supports sustained adoption of wearable and telemetry-enabled services.
Europe
Europe accounted for 25.9% share in 2025. Cardiac monitoring market performance is supported by established cardiology networks and broad access to diagnostic services across major economies. Hospitals and diagnostic centers maintain steady monitoring volumes through standardized rhythm assessment and follow-up practices. Demand is reinforced by modernization of monitoring infrastructure and expansion of ambulatory pathways. Adoption patterns vary by country due to reimbursement differences and procurement cycles.
Asia Pacific
Asia Pacific accounted for 21.7% share in 2025. Cardiac monitoring market growth in the region benefits from expanding access to hospital services, rising awareness of cardiovascular risk, and increasing adoption of ambulatory care pathways in metropolitan centers. Infrastructure investment supports greater deployment of monitoring devices across public and private systems. Demand accelerates as specialized cardiac programs expand and monitoring becomes more integrated into routine care. Market growth remains uneven across countries due to differences in affordability and clinical capacity.
Latin America
Latin America accounted for 6.2% share in 2025. Cardiac monitoring market adoption is concentrated in larger economies with stronger private-sector healthcare capacity and higher access to diagnostics. Budget constraints and uneven distribution of specialty services limit penetration of advanced monitoring technologies in smaller markets. Diagnostic centers play an important role in expanding access to monitoring in urban areas. Gradual expansion of remote monitoring programs creates incremental opportunities across private providers.
Middle East & Africa
Middle East & Africa accounted for 3.4% share in 2025. Cardiac monitoring market deployment is driven by expansion of tertiary care centers and modernization initiatives in select countries. Adoption is strongest in regions with higher healthcare spending and established specialist services. Access constraints and procurement limitations continue to slow broad penetration across many markets. Remote monitoring pilots and network expansion create longer-term opportunity as infrastructure matures.
Competitive Landscape
Cardiac monitoring market competition centers on portfolio breadth, enterprise integration, and differentiated ambulatory monitoring capabilities across hospital, outpatient, and home-care pathways. Major players compete through integrated ecosystems that combine devices, software, and services to improve workflow efficiency and clinical decision support. Differentiation increasingly depends on connectivity, analytics-supported interpretation, and scalable remote monitoring programs. Partnerships, product refresh cycles, and clinical evidence generation remain key levers to expand adoption across provider networks.
Abbott emphasizes long-duration monitoring and ecosystem integration that supports clinical workflows across diagnosis, follow-up, and remote surveillance. Abbott positions monitoring solutions to reduce fragmentation between device data and clinical decision-making pathways. Abbott also benefits from a broad medtech footprint that supports cross-selling within cardiology service lines. Abbott continues to align monitoring offerings with expanding ambulatory and home-based care models.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In April 2025, LifeSignals, Inc. launched the UbiqVue 2AYe Holter System in partnership with UltraLinQ Healthcare Solutions at Heart Rhythm 2025. The company said the new Holter solution is built to speed cardiac monitoring workflows, uses a single-use chest-worn biosensor, collects 2-channel ECG and event data for up to five days, and transmits encrypted patient data to a cloud-based analytics platform for faster report delivery.
In April 2025, CardioOne acquired CardioDiagnostics to strengthen its virtual cardiology and remote cardiac monitoring capabilities for physician practices. CardioOne later stated that the acquisition was intended to support a broader value-based cardiology care model, and the acquired capabilities were incorporated into its CardioOne Connect monitoring and care platform announced in January 2026.
In September 2025, Health-E Commerce and Biotricity announced a partnership to expand access to Biotricity’s Bioheart wearable cardiac monitoring solution. The collaboration makes Bioheart available to more than 70 million consumers enrolled in FSA and HSA programs, which broadens consumer access to continuous 24/7 cardiac monitoring technology
Report Scope
Report Attribute
Details
Market size value in 2025
USD 28361 million
Revenue forecast in 2032
USD 39115.64 million
Growth rate (CAGR)
4.7% (2025–2032)
Base year
2025
Forecast period
2026-2032
Quantitative units
USD million
Segments covered
By Product Type Outlook: Resting ECG, Stress ECG, Holter Monitors, Event Monitors, Mobile Cardiac Telemetry, Implantable Cardiac Monitoring, Wearable Patch Monitors, Others; By Technology Outlook: Conventional (Wired), Wireless & Wearable, AI-Enabled Analytics Platforms; By End User Outlook: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings, Others
Regional scope
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Key companies profiled
Abbott; AliveCor, Inc.; Baxter; BIOTRONIK; Boston Scientific Corporation; GE HealthCare; iRhythm Technologies, Inc.; Koninklijke Philips N.V.; Medtronic plc; MicroPort Scientific Corporation; NIHON KOHDEN CORPORATION; OSI Systems, Inc.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Stryker
No. of Pages
324
By Segmentation
By Product Type
Resting ECG
Stress ECG
Holter Monitors
Event Monitors
Mobile Cardiac Telemetry
Implantable Cardiac Monitoring
Wearable Patch Monitors
Others
By Technology
Conventional (Wired)
Wireless & Wearable
AI-Enabled Analytics Platforms
By End User
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers
Homecare Settings
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
1. Introduction
1.1 Report Description
1.2 Purpose of the Report
1.3 USP & Key Offerings
1.4 Key Benefits for Stakeholders
1.5 Target Audience
1.6 Report Scope
1.7 Regional Scope 2. Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology 3. Executive Summary
4. Market Overview
4.1 Overview
4.2 Key Industry Trends 5. Global Cardiac Monitoring Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast 6. Market Breakup by Product Type
6.1 Resting ECG
6.2 Stress ECG
6.3 Holter Monitors
6.4 Event Monitors
6.5 Mobile Cardiac Telemetry
6.6 Implantable Cardiac Monitoring
6.7 Wearable Patch Monitors
6.8 Others 7. Market Breakup by Technology
7.1 Conventional (Wired)
7.2 Wireless & Wearable
7.3 AI-Enabled Analytics Platforms 8. Market Breakup by End User
8.1 Hospitals
8.2 Diagnostic Centers
8.3 Ambulatory Surgical Centers
8.4 Homecare Settings
8.5 Others 9. Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.2 Canada
9.2 Asia-Pacific
9.2.1 China
9.2.2 Japan
9.2.3 India
9.2.4 South Korea
9.2.5 Australia
9.2.6 Indonesia
9.2.7 Others
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 United Kingdom
9.3.4 Italy
9.3.5 Spain
9.3.6 Russia
9.3.7 Others
9.4 Latin America
9.4.1 Brazil
9.4.2 Mexico
9.4.3 Others
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast 10. SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats 11. Value Chain Analysis 12. Porter’s Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes 13. Price Analysis 14. Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott
14.3.2 AliveCor, Inc.
14.3.3 Baxter
14.3.4 BIOTRONIK
14.3.5 Boston Scientific Corporation
14.3.6 GE HealthCare
14.3.7 iRhythm Technologies, Inc.
14.3.8 Koninklijke Philips N.V.
14.3.9 Medtronic plc
14.3.10 MicroPort Scientific Corporation
14.3.11 NIHON KOHDEN CORPORATION
14.3.12 OSI Systems, Inc.
14.3.13 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
14.3.14 Stryker 15. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the market size of the Cardiac monitoring market in 2025 and the forecast for 2032?
The Cardiac monitoring market size was USD 28361 million in 2025. The Cardiac monitoring market is expected to reach USD 39115.64 million by 2032.
What is the CAGR of the Cardiac monitoring market during 2025–2032?
The Cardiac monitoring market is projected to grow at a CAGR of 4.7% during 2025–2032. Growth is supported by expanding ambulatory monitoring and remote-care pathways.
Which segment holds the largest share in the Cardiac monitoring market?
Resting ECG held the largest share at 33.4% in 2025. High routine diagnostic use across screening, triage, and follow-up supports leadership.
What factors are driving growth in the Cardiac monitoring market?
Remote monitoring expansion, higher diagnostic intensity, and longer-duration rhythm surveillance programs support demand. Workflow integration and analytics also strengthen adoption across care settings.
Who are the leading companies in the Cardiac monitoring market?
Key companies include Abbott, Medtronic plc, Koninklijke Philips N.V., GE HealthCare, and Boston Scientific Corporation. Other profiled companies include AliveCor, BIOTRONIK, iRhythm Technologies, MicroPort, NIHON KOHDEN, OSI Systems, Mindray, Baxter, and Stryker.
Which region leads the Cardiac monitoring market?
North America leads with 42.8% share in 2025. Advanced care infrastructure and higher uptake of connected monitoring workflows sustain leadership.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
US Ultraviolet disinfection equipment Market was valued at USD 572.8 million in 2024 and is anticipated to reach USD 1611.2 million by 2032, growing at a CAGR of 13.8% during the forecast period.
The AI-based digital pathology market was valued at USD 1,093.72 million in 2024 and is projected to reach USD 2,069.83 million by 2032, expanding at a CAGR of 8.3% during the forecast period.
The Proliferative Diabetic Retinopathy Market size was valued at USD 2,499 million in 2024 and is anticipated to reach USD 4677.35 million by 2032, at a CAGR of 8.15 % during the forecast period.
Electronic Stethoscope Market size was valued USD 234 Million in 2024 and is anticipated to reach USD 511.77 Million by 2032, at a CAGR of 10.3% during the forecast period.
Emergency Hospital Bed market size was valued at USD 1,847 million in 2024 and is anticipated to reach USD 2,413.79 million by 2032, growing at a CAGR of 3.4% during the forecast period.
The global Digital Neurotherapeutics Market size was estimated at USD 2,965.30 million in 2025 and is expected to reach USD 8,310.95 million by 2032, growing at a CAGR of 18.74% from 2025 to 2032.
The global Digital Immunohistochemistry Market size was estimated at USD 1,850.65 million in 2025 and is expected to reach USD 3,514.20 million by 2032, growing at a CAGR of 11.28% from 2025 to 2032.
The global Digital Dentistry Market size was estimated at USD 8,120.40 million in 2025 and is expected to reach USD 14,128.77 million by 2032, growing at a CAGR of 9.67% from 2025 to 2032.
The global Diathermy Equipment Market size was estimated at USD 482.63 million in 2025 and is expected to reach USD 688.89 million by 2032, growing at a CAGR of 6.11% from 2025 to 2032.
The global Dialysis Concentrate Market size was estimated at USD 2,186.74 million in 2025 and is expected to reach USD 2,991.24 million by 2032, growing at a CAGR of 5.36% from 2025 to 2032.
The global Diagnostics Enzyme Market size was estimated at USD 3,214.59 million in 2025 and is expected to reach USD 4,972.17 million by 2032, growing at a CAGR of 7.54% from 2025 to 2032.
The global Diagnostic Radiopharmaceuticals Contrast Media Market size was estimated at USD 14,726.84 million in 2025 and is expected to reach USD 21,343.69 million by 2032, growing at a CAGR of 6.38% from 2025 to 2032.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$3999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$4999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
